Bioanalytical testing firm Eurofins Scientific on Tuesday announced it has raised 600 million euros ($632.1 million) in a senior, unsecured public bond issue.
The bonds have a seven-year maturity, due on July 6, 2029, and will bear an annual fixed-rate coupon of 4%.
The Luxembourg-based firm said the transaction was oversubscribed. It will use the bond proceeds to manage the repurchase of 300 million euro fixed-to-floating rate bonds issued September 11, 2019 and 300 million euro fixed-to-floating rate bonds issued April 29, 2015 that are currently under tender offers, the firm said.